Injectable Nutritional Supplement
Patent No. EP3996720 (titled "Injectable Nutritional Supplement") was filed by Chemvet Australia on Jul 7, 2020. The application was issued on Feb 12, 2025.
Patent Summary
An aqueous injectable nutritional supplement for livestock comprises an EDTA complex of one or more trace elements, vitamin B12, and a water-soluble liquid. The trace elements, selected from zinc, copper, manganese, selenium, and chromium, are present at 1 g to 100 g per litre, based on the element itself. The water-soluble liquid, present at 20 g to 300 g per litre, is selected from propylene glycol, polyethylene glycol (MW $\le$ 300), glycol ethers (MW $\le$ 300), dipropylene glycol monomethyl ether, or mixtures thereof. The composition is designed to stabilize vitamin B12 against degradation exacerbated by high trace element concentrations, providing a storage-stable formulation for subcutaneous administration to enhance livestock productivity.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3996720
- Application Number
- EP20838886A
- Filing Date
- Jul 7, 2020
- Status
- Granted And Under Opposition
- Jan 10, 2025
- Publication Date
- Feb 12, 2025
- External Links
- Slate, Register , Google Patents